Addressing Liver Cancer Disparities & Advancing TreatmentGlobal Liver Institute brings you key updates in liver cancer care and health equity. This edition features a 5-year update on the...
First Ever Rare Liver Disease Patient Cured with Personalized Gene Therapy Treatment Collaboration and Ideas Driven from Conversations at EASL Congress, Amsterdam Kristin Hatcher,...
Together for Better Liver Health: WHA78 Side Event Unites Global Stakeholders to Strengthen Public Health Responses to Metabolic DiseaseGeneva, Switzerland - 23 May 2025 - Global health leaders call...
Global Health Leaders Convene at WHA78 Side Event to Advocate for Steatotic Liver Disease as a Core Non-Communicable DiseaseGeneva, Switzerland – 22 May 2025 – Leading health organizations,...
The Frontline Role of Primary Care in Hepatitis B CareChronic infection of the liver by hepatitis B virus (HBV) remains a significant public health concern in the U.S. and around the world,...
Congress returns with budget reconciliation at the top of the to-do list. Key House authorizing committees are slated to kick off markups on their respective budget reconciliation instructions that...
Big Wins for Rare Liver Disease: New Codes, Drug Approvals, and Global Advocacy – Pediatric and Rare Liver Diseases News New ICD-10 Codes for Fontan-Associated Conditions The...
Treatment Advances & Prevention ResearchGlobal Liver Institute brings you key updates in liver cancer research and treatment. We highlight the final results from a Phase II combination therapy...
Liver Health Insights, Events, and a Global ChallengeA Note from the Director, Dr. Sharon H. Jaycox I recently conducted a workshop titled: Advanced Strategies: Navigating Credible Research and...
GLI Statement on the CMS 2026 Medicare Advantage and Part D Final Rule and Anti-Obesity Medication Coverage WASHINGTON, DC – On Friday, April 4, 2025, the U.S. Centers for Medicare and Medicaid...
Recent News
Culturally Relevant Tools to Increase Hepatitis B Screening in Asian American CommunitiesInfection with hepatitis B poses a serious risk to the health of many Americans – especially in certain groups with high risk, including Asian Americans and Asian-American...
Global Liver Institute Leads Efforts in Urging FDA to Recognize Patient-Defined Progress in Drug Development(Washington, D.C. June 24, 2025) – At the Global Liver Institute, we believe that it all starts with a patient because only they define what progress means to...
TROA Reintroduced, Veterans Health Advances, Hep C Bill Introduced, and Senate Considers Medicaid Cuts The House passed H.R. 1, the One Big, Beautiful Bill Act, sending the budget reconciliation package to the Senate. Join Global Liver Institute to Push Congress to...
GLI Works With Congress to Protect Veterans’ Health(Washington, D.C., June 11, 2025) – Global Liver Institute (GLI), in close coordination with congressional staff, has worked tirelessly to ensure that veterans diagnosed with NASH/MASH have no barriers to their care...
Global Fatty Liver Day 2025: Elevating Liver Health in the Metabolic Health ConversationGlobal Liver Institute Calls for Urgent Action as Fatty Liver Disease Prevalence Surges Worldwide (Washington, D.C., June 12, 2025) – On the second Thursday in June, Global Fatty...
